Flow Diversion for Treatment of Partially Thrombosed Aneurysms: A Multicenter Cohort.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 28 08 2019
revised: 13 11 2019
accepted: 14 11 2019
pubmed: 25 11 2019
medline: 28 3 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

Partially thrombosed intracranial aneurysms (PTIA) represent a unique subset of intracranial aneurysms with an ill-defined natural history, posing challenges to standard management strategies. This study aims to assess the efficacy of flow diversion in the treatment of this pathology. A retrospective review of patients with flow-diverted PTIA at 6 cerebrovascular centers was performed. Clinical and radiographic data were collected from the medical records, with the primary outcome of aneurysmal occlusion and secondary outcomes of clinical status and complications. Fifty patients with 51 PTIA treated with flow diversion were included. Median age was 56.5 years. Thirty-three (64.7%) aneurysms were saccular and 16 (31.4%) were fusiform/dolichoectatic. The most common location was the internal carotid artery (54.9%) followed by the vertebral and basilar arteries (17.7% and 17.7%, respectively). Last imaging follow-up was performed at a median of 25.1 (interquartile range, 12.8-43) months. Complete occlusion at last radiographic follow-up was achieved in 37 (77.1%) aneurysms. Pretreatment aneurysm thrombosis of >50% was associated with a significantly lower rate of complete aneurysm occlusion (58.8 vs. 87.1%, P = 0.026) with a trend toward better functional outcome (modified Rankin scale <2) at last follow-up in patients with <50% pretreatment aneurysm thrombosis (96.8 vs. 82.4; P = 0.08). Ischemic complications occurred in 5 (9.8%) patients, producing symptoms in 4 (7.8%) and resultant mortality in 2 (4.2%) patients. Flow diversion treatment of PTIA has adequate efficacy along with a reasonable safety profile. Aneurysms harboring large amounts of pretreatment thrombus were associated with lower rates of complete occlusion.

Sections du résumé

BACKGROUND BACKGROUND
Partially thrombosed intracranial aneurysms (PTIA) represent a unique subset of intracranial aneurysms with an ill-defined natural history, posing challenges to standard management strategies. This study aims to assess the efficacy of flow diversion in the treatment of this pathology.
METHODS METHODS
A retrospective review of patients with flow-diverted PTIA at 6 cerebrovascular centers was performed. Clinical and radiographic data were collected from the medical records, with the primary outcome of aneurysmal occlusion and secondary outcomes of clinical status and complications.
RESULTS RESULTS
Fifty patients with 51 PTIA treated with flow diversion were included. Median age was 56.5 years. Thirty-three (64.7%) aneurysms were saccular and 16 (31.4%) were fusiform/dolichoectatic. The most common location was the internal carotid artery (54.9%) followed by the vertebral and basilar arteries (17.7% and 17.7%, respectively). Last imaging follow-up was performed at a median of 25.1 (interquartile range, 12.8-43) months. Complete occlusion at last radiographic follow-up was achieved in 37 (77.1%) aneurysms. Pretreatment aneurysm thrombosis of >50% was associated with a significantly lower rate of complete aneurysm occlusion (58.8 vs. 87.1%, P = 0.026) with a trend toward better functional outcome (modified Rankin scale <2) at last follow-up in patients with <50% pretreatment aneurysm thrombosis (96.8 vs. 82.4; P = 0.08). Ischemic complications occurred in 5 (9.8%) patients, producing symptoms in 4 (7.8%) and resultant mortality in 2 (4.2%) patients.
CONCLUSIONS CONCLUSIONS
Flow diversion treatment of PTIA has adequate efficacy along with a reasonable safety profile. Aneurysms harboring large amounts of pretreatment thrombus were associated with lower rates of complete occlusion.

Identifiants

pubmed: 31760188
pii: S1878-8750(19)32924-9
doi: 10.1016/j.wneu.2019.11.084
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e164-e173

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Paul M Foreman (PM)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania, USA; Orlando Health, Neuroscience and Rehabilitation Institute, Orlando, Florida, USA. Electronic address: pforeman@geisinger.edu.

Mohamed M Salem (MM)

Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, USA.

Christoph J Griessenauer (CJ)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania, USA; Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.

Adam A Dmytriw (AA)

Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Carmen Parra-Farinas (C)

Department of Interventional Neuroradiology, St. Michael's Hospital, Toronto, Ontario, Canada.

Patrick Nicholson (P)

Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Nicola Limbucci (N)

Department of Interventional Neuroradiology, University of Florence, Florence, Italy.

Anna Luisa Kühn (AL)

Division of Neuroradiology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, USA.

Ajit S Puri (AS)

Division of Neuroimaging and Intervention, Department of Radiology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA.

Leonardo Renieri (L)

Department of Interventional Neuroradiology, University of Florence, Florence, Italy.

Sergio Nappini (S)

Department of Interventional Neuroradiology, University of Florence, Florence, Italy.

Kimberly P Kicielinski (KP)

Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, USA.

Alejandro Bugarini (A)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania, USA.

Vitor Mendes Pereira (VM)

Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Thomas R Marotta (TR)

Department of Interventional Neuroradiology, St. Michael's Hospital, Toronto, Ontario, Canada.

Clemens M Schirmer (CM)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System, Danville, Pennsylvania, USA.

Christopher S Ogilvy (CS)

Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, USA.

Ajith J Thomas (AJ)

Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH